artesunic acid has been researched along with Plasmodium vivax Malaria in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (2.56) | 18.2507 |
2000's | 23 (29.49) | 29.6817 |
2010's | 48 (61.54) | 24.3611 |
2020's | 5 (6.41) | 2.80 |
Authors | Studies |
---|---|
Boechat, N; Campos Aguiar, AC; da Silva Araújo, M; Krettli, AU; Medeiros, JF; Penna-Coutinho, J; Pereira, DB; Rios, CT; Sá, PM | 1 |
Alexander, K; Anstey, NM; Buffet, PA; Candrawati, F; Kambuaya, NN; Kenangalem, E; Kho, S; Leonardo, L; Margayani, DS; Poespoprodjo, JR; Prayoga, P; Rini, H; Shanti, PAI; Yayang, BTG | 1 |
Baird, JK; Cui, L; He, X; Huang, Y; Lu, Y; Pan, M; Pi, L; Qin, P; Qin, Y; Yang, Z; Zeng, W; Zhao, L; Zou, C | 1 |
Kaur, M; Saha, A; Tripathi, N | 1 |
Alberer, M; Bélard, S; Blohm, M; Brand, J; Gratopp, A; Hübner, J; Hufnagel, M; Janda, A; Kempf, C; Kobbe, R; Krüger, R; Kurth, F; Mall, M; Reiter, K; Schulze-Sturm, U; Stegemann, MS; Suttorp, N; Tacoli, C; Varnholt, V; von Bernuth, H; von Both, U; Zoller, T | 1 |
Kim, S; Lek, D; Mairet-Khedim, M; Popovici, J; Roesch, C; Witkowski, B | 1 |
Dixit, S; Garg, N; Gupta, R; Kotru, M | 1 |
Adamo, G; Ascoli Bartoli, T; Bevilacqua, N; Buffet, P; Corpolongo, A; D'Abramo, A; Giancola, ML; Ippolito, G; Lepore, L; Mariano, A; Nicastri, E; Palazzolo, C; Scorzolini, L | 1 |
Ataide, R; Beeson, JG; Boel, M; Drew, D; Fowkes, FJI; McGready, R; McLean, ARD; Nosten, F; Simpson, JA; Tsuboi, T | 1 |
Bhadauria, D; Gupta, A; Jain, M; Kaul, A; Prasad, N; Sharma, RK; Vardhan, H | 1 |
Aung, AA; Bancone, G; Carrara, VI; Cheah, PY; Chu, CS; Chue, AL; Imwong, M; Lwin, KM; Moore, KA; Nosten, F; Phyo, AP; Proux, S; Raksapraidee, R; San, T; Sriprawat, K; Tarning, J; Watson, J; White, NJ; Wiladphaingern, J; Win, HH; Winterberg, M | 1 |
Blessborn, D; Chairat, K; Day, NPJ; Hanboonkunupakarn, B; Hanpithakpong, W; Jittamala, P; Pukrittayakamee, S; Tarning, J; White, NJ | 1 |
Arbe-Barnes, S; Borghini-Fuhrer, I; Craft, CJ; Duparc, S; Fleckenstein, L; Miller, RM; Shin, CS | 1 |
Arya, V; Gathwala, G; Gehlawat, VK; Kaushik, JS | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Aggarwal, V; Agrawal, Y; Dhingra, B; Kanwal, SK; Kumar, V; Nagpal, A | 1 |
Burkholder, B; Bustos, MD; Delacollette, C; Wongsrichanalai, C | 1 |
Sharma, P; Varma, N | 1 |
Agrawal, R; Khatri, PC; Kochar, DK; Lahoti, A; Tanwar, GS; Tanwar, P | 1 |
Bhalla, A; Kaur, G; Kumar, PS; Kumar, S; Sharma, N; Varma, S | 1 |
Chotivanich, K; Chu, CS; McGready, R; Nosten, F; Tun, NW; White, NJ; Wongsaen, K | 1 |
Agrawal, B; Kumar, M; Kumar, S; Kumari, R | 1 |
Arboleda, M; Blair, S; Fernández, D; Garavito, G; Pabón, A; Segura, C | 1 |
Ashley, EA; Blessborn, D; Chairat, K; Day, NP; Hanboonkunupakarn, B; Jittamala, P; Lee, SJ; Nosten, F; Panapipat, S; Pukrittayakamee, S; Tarning, J; Thana, P; White, NJ | 1 |
Changpradub, D; Mungthin, M | 1 |
Adekunle, AI; Cromer, D; Davenport, MP; Luxemburger, C; McGready, R; Nosten, F; Pinkevych, M; White, LJ | 1 |
Chen, WQ; Liu, Y; Qian, D; Xu, BL; Yang, CY; Zhang, HW; Zhao, YL; Zhou, RM | 1 |
Auburn, S; Handayuni, I; Marfurt, J; Noviyanti, R; Pava, Z; Poespoprodjo, JR; Price, RN; To, S; Trianty, L; Wirjanata, G | 1 |
Bannister-Tyrrell, M; Coosemans, M; d'Alessandro, U; Dierickx, S; Durnez, L; Erhart, A; Gerrets, R; Gryseels, C; Hausmann-Muela, S; Hoibak, S; Muela Ribera, J; Peeters Grietens, K; Phoeuk, P; Set, S; Sluydts, V; Suon, S; Tho, S; Trienekens, S; Uk, S | 1 |
Ayyoub, A; Borghini-Fuhrer, I; Djimde, AA; Duparc, S; Fleckenstein, L; Methaneethorn, J; Ramharter, M; Shin, JS; Tekete, M | 1 |
Bhatt, AN; Dhunputh, P; Gupta, H; Satyamoorthy, K; Umakanth, S | 1 |
Aguirre-Acevedo, DC; Tamayo Perez, ME; Zuluaga-Idarraga, LM | 1 |
Beeching, NJ; Bell, DJ; Chiodini, PL; Lalloo, DG; Shingadia, D; Whitty, CJM | 1 |
Kandasamy, D; Lodha, R; Rathia, SK; Sankar, J | 1 |
Anstey, NM; Auburn, S; Barber, BE; Edstein, MD; Grigg, MJ; Menon, J; Price, RN; Rajahram, GS; Wilkes, CS; William, T; Yeo, TW | 1 |
Abdullah, HM; Qadir, S; Shahzad, MA; Ullah, W | 1 |
Amireh, S; Guron, G; Shaaban, H | 1 |
Jain, S; Kumari, S; Lakshman, A; Sharma, N; Singh, C; Singhal, M; Varma, S | 1 |
Choudhury, J; Ghosh, A; Sharma, S | 1 |
Agbenyega, T; Babiker, A; Baiden, F; Binka, F; Clerk, C; Faiz, MA; Folb, P; Gomes, MF; Gyapong, JO; Hassan, R; Hossain, MA; Kimbute, O; Kitua, A; Krishna, S; Makasi, C; Mensah, N; Mrango, Z; Olliaro, P; Peto, R; Peto, TJ; Rahman, MR; Ribeiro, I; Samad, R; Warsame, M; White, NJ; Yunus, EB | 1 |
Davis, TM; Gomorrai, PS; Griffin, S; Ilett, KF; Karunajeewa, HA; Kotab, K; Lautu, D; Law, I; Lin, E; Mueller, I; Oa, O; Page-Sharp, M; Salman, S; Senn, M; Siba, P; Suano, P; Tarongka, N; Ura, A; Wong, R | 1 |
Ariey, F; Chim, P; Lim, P; Muth, S; Rogers, WO; Sem, R; Socheat, D; Tero, T; Wongsrichanalai, C | 1 |
Chakrabartty, S; Patra, VS; Ranjan, R; Thapa, R | 1 |
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
Avabratha, KS; Chettiyar, LA; John, NP | 1 |
Sanghai, SR; Shah, I | 1 |
Borghini-Fuhrer, I; Duparc, S; Fleckenstein, L; Poravuth, Y; Purnama, A; Pyae Phyo, A; Rao, BH; Rueangweerayut, R; Shin, CS; Socheat, D; Tjitra, E; Uthaisin, C; Valecha, N | 1 |
Terlouw, DJ; van Eijk, AM | 1 |
Sonkar, GK; Sonkar, SK; Uniyal, R | 1 |
Afsharpad, M; Djadid, ND; Pirahmadi, S; Zakeri, S | 1 |
Alonso, PL; Bassat, Q; Betuela, I; Kiniboro, B; Mueller, I; Robinson, LJ; Rosanas-Urgell, A; Siba, PM; Stanisic, D | 1 |
Bagalkot, PS; Joshi, SN; Maralihalli, MB; Prashanth, GP | 1 |
Boulos, M; Daher, A; dos Santos, RL; Junger, W; Ladislau, JL; Leon, AP; Lucena, MB; Magalhães, I; Marchesini, PB; Ribeiro, I; Santelli, AC | 1 |
Alonso, PL; Bassat, Q; Betuela, I; de Lazzari, E; Del Portillo, HA; Kiniboro, B; Mueller, I; Rosanas-Urgell, A; Samol, L; Siba, P; Stanisic, DI | 1 |
Kusriastuti, R; Surya, A | 1 |
Anstey, NM; Auburn, S; Barber, BE; Grigg, MJ; Marfurt, J; Menon, J; William, T; Yeo, TW | 1 |
Alva, J; Bhat, S; Fahad, S; Muralidhara, K | 1 |
Baird, JK; Basri, H; Ekawati, LL; Elyazar, I; Farrar, J; Meilia, RA; Nurleila, S; Putri, FA; Setiabudy, R; Sudoyo, H; Sutanto, I; Taylor, WR; Tjahjono, B | 1 |
Phan, VT | 1 |
Anstey, NM; Baker, J; Cheng, Q; Suprianto, S; Tjitra, E | 1 |
Campos, SB; Seguro, AC | 1 |
Alpers, MP; Batty, KT; Davis, TM; Ilett, KF; Karunajeewa, HA; Kemiki, A; Lorry, K | 1 |
Brittenham, GM; Chalearmrult, K; Gourdeuk, VR; Krudsood, S; Looareesuwan, S; Maneekan, P; Mint, HY; Silachamroon, U; Treeprasertsuk, S; White, NJ; Wilairatana, P | 1 |
Brockman, A; Katterman, N; Kyaw, MK; Lwin, S; Smithuis, F; van der Broek, I; White, NJ | 1 |
Fontanet, A; Looareesuwan, S; Nacher, M; Phumratanaprapin, W; Silachamroon, U; Singhasivanon, P; Wilairatana, P | 1 |
Hamedi, Y; Kojima, S; Looareesuwan, S; Safa, O; Tan-ariya, P; Zare, S | 1 |
Arbe-Barnes, S; Brun, R; Kocken, CH; Matile, H; Scheurer, C; Thomas, AW; van der Wel, A; Wittlin, S | 1 |
Ashley, EA; Brockman, A; Carrara, VI; Gilbos, V; Krudsood, S; Leemingsawat, S; Looareesuwan, S; McGready, R; Nosten, F; Proux, S; Rojanawatsirivet, C; Singhasivanon, P; Sirilak, S; Thonglairuam, J; White, N | 1 |
Ashley, EA; Barends, M; Leowattana, W; Lwin, KM; McGready, R; Nawamaneerat, W; Nosten, F; Olliaro, P; Phaiphun, L; Proux, S; Simon, WH; Singhasivanon, P; Stepniewska, K; Taylor, W; Thwai, KL; Wangseang, N; White, NJ | 1 |
Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Maristela, R; Penttinen, PM; Price, RN; Purba, HL; Tjitra, E; Wuwung, RM | 1 |
Chavchich, M; Cuong, BT; Dai, B; Dao, NV; Duy, DN; Edstein, MD; Ngoa, ND; Rieckmann, KH; Thanh, NX; The, ND; Thuy, le TT | 1 |
Beeson, JG; Cole-Tobian, JL; Dabod, E; Igu, J; King, CL; Michon, P; Mueller, I; Reeder, JC; Schoepflin, S; Schofield, L; Susapu, M; Tarongka, N; Zimmerman, PA | 1 |
Durrani, N; Kolaczinski, K; Rahim, S; Rowland, M | 1 |
Cole-Tobian, JL; Dabod, E; King, CL; Michon, P; Mueller, I | 1 |
Batty, KT; Davis, TM; Huynh, VT; Ilett, KF; Le, AT; Nguyen, CH; Nguyen, PT; Nguyen, VM; Powell, SM; Tran, QB; Truong, XM; Vuong, VC | 1 |
Bussaratid, V; Krudsood, S; Looareesuwan, S; Phumratanaprapin, W; Silachamroon, U; Singhasivanon, P; Srivilirit, S; Treeprasertsuk, S; Wilairatana, P | 1 |
Brewer, TG; Charles, BG; Eamsila, C; Edstein, MD; Kocisko, DA; Walsh, DS | 1 |
6 review(s) available for artesunic acid and Plasmodium vivax Malaria
Article | Year |
---|---|
Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.
Topics: Adult; Antimalarials; Artesunate; Coombs Test; Female; Hemolysis; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Parasitemia; Young Adult | 2021 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Directly Observed Therapy; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Quinolines | 2013 |
Therapeutic efficacy of alternative primaquine regimens to standard treatment in preventing relapses by Plasmodium vivax: A systematic review and meta-analysis.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Administration Schedule; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine; Recurrence; Secondary Prevention | 2015 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
21 trial(s) available for artesunic acid and Plasmodium vivax Malaria
Article | Year |
---|---|
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
Topics: Adolescent; Adult; Antimalarials; Artesunate; Child; Child, Preschool; Chloroquine; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Middle Aged; Myanmar; Parasitemia; Plasmodium vivax; Primaquine; Recurrence; Thailand; Treatment Outcome; Young Adult | 2018 |
Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Malaria, Vivax; Male; Middle Aged; Primaquine; Quinolines; Thailand; Young Adult | 2018 |
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
Topics: Administration, Oral; Adult; Antimalarials; Artemisinins; Artesunate; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Primaquine; Thailand; Young Adult | 2015 |
Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients.
Topics: Adolescent; Antimalarials; Area Under Curve; Artemisinins; Artesunate; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Models, Theoretical; Naphthyridines | 2015 |
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Resistance; Female; Humans; Infant; Malaria, Vivax; Male; Mefloquine; Middle Aged; Plasmodium vivax; Treatment Outcome; Young Adult | 2016 |
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.
Topics: Administration, Rectal; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Disabled Persons; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Placebos; Rural Health Services; Suppositories; Young Adult | 2009 |
A trial of combination antimalarial therapies in children from Papua New Guinea.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Child, Preschool; Chloroquine; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Lumefantrine; Malaria, Falciparum; Malaria, Vivax; Male; Proportional Hazards Models; Pyrimethamine; Quinolines; Recurrence; Sulfadoxine | 2008 |
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Time Factors; Treatment Outcome; Young Adult | 2011 |
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Topics: Antimalarials; Artemisinins; Artesunate; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Primaquine; Recurrence; Risk Factors; Time Factors | 2012 |
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance; Drug Therapy, Combination; Humans; Indonesia; Malaria; Malaria, Vivax; Male; Military Personnel; Plasmodium vivax; Primaquine; Quinine; Quinolines; Secondary Prevention | 2013 |
Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations.
Topics: Adolescent; Adult; Animals; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Vivax; Male; Plasmodium vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2002 |
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
Topics: Administration, Oral; Adolescent; Animals; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Primaquine; Sesquiterpenes; Thailand | 2003 |
Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Hemoglobins; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Rural Health; Sesquiterpenes | 2004 |
Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Sesquiterpenes; Thailand; Treatment Outcome | 2004 |
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quality Control; Sesquiterpenes; Tablets; Thailand; Treatment Outcome | 2006 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Artesunate; Drug Resistance, Multiple; Drug Tolerance; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Quinolines; Sesquiterpenes; Treatment Outcome | 2007 |
Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Topics: Adolescent; Afghanistan; Antimalarials; Artemisinins; Artesunate; Child; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Endemic Diseases; Humans; Malaria, Falciparum; Malaria, Vivax; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.
Topics: Administration, Oral; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Biological Availability; Cross-Over Studies; Half-Life; Humans; Injections, Intravenous; Malaria, Vivax; Male; Parasitemia; Plasmodium vivax; Sesquiterpenes; Vietnam | 1998 |
Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Topics: Adolescent; Adult; Aged; Animals; Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 1999 |
Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
Topics: Administration, Oral; Adult; Aminoquinolines; Antimalarials; Artemisinins; Artesunate; Computer Simulation; Doxycycline; Half-Life; Humans; Malaria, Vivax; Male; Metabolic Clearance Rate; Middle Aged; Military Personnel; Models, Biological; Observer Variation; Sesquiterpenes; Thailand | 2001 |
51 other study(ies) available for artesunic acid and Plasmodium vivax Malaria
Article | Year |
---|---|
MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Topics: Animals; Antimalarials; Artesunate; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax | 2021 |
Case Report: Severe Plasmodium vivax Malaria after Splenectomy.
Topics: Artesunate; Humans; Malaria; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Splenectomy | 2023 |
Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Cytochrome P-450 CYP2D6; Ghana; Humans; Inactivation, Metabolic; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Recurrence | 2019 |
Multiple Splenic Infarcts Complicating Plasmodium vivax Malaria.
Topics: Acute Kidney Injury; Administration, Intravenous; Administration, Oral; Adolescent; Antimalarials; Artesunate; Diagnosis, Differential; Humans; Malaria, Vivax; Male; Plasmodium vivax; Primaquine; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Intravenous Artesunate for Imported Severe Malaria in Children Treated in Four Tertiary Care Centers in Germany: A Retrospective Study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Antimalarials; Artesunate; Child; Child, Preschool; Communicable Diseases, Imported; Female; Germany; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Parasitemia; Retrospective Studies; Tertiary Care Centers | 2019 |
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Topics: Antimalarials; Artemisinins; Artesunate; Cambodia; DNA Copy Number Variations; Drug Resistance; Humans; Malaria, Vivax; Mefloquine; Pharmaceutical Preparations; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Quinolines | 2020 |
Plasmodium Vivax Malaria: Usual Illness with Dysregulated Immune Profile.
Topics: Adult; Artesunate; Humans; Immunoglobulins, Intravenous; Malaria, Vivax; Male; Plasmodium vivax; Thrombocytopenia | 2020 |
Antibody Responses to
Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Cohort Studies; Disease Resistance; Disease Susceptibility; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Merozoite Surface Protein 1; Parasitemia; Parturition; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Proportional Hazards Models; Risk; Time Factors | 2017 |
P. vivax Malaria presenting as Thrombotic Microangiopathy.
Topics: Acute Kidney Injury; Adult; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria, Vivax; Male; Parasitemia; Plasmapheresis; Renal Dialysis; Retrospective Studies; Thrombotic Microangiopathies; Young Adult | 2017 |
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials.
Topics: Adolescent; Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Naphthyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2013 |
Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India.
Topics: Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Blood; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; India; Malaria, Vivax; Male; Prospective Studies; Tertiary Care Centers; Treatment Outcome | 2013 |
Plasmodium vivax malaria complicated by splenic infarct.
Topics: Abdomen; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Blood; Child; Female; Humans; Malaria, Vivax; Plasmodium vivax; Radiography, Abdominal; Spleen; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2014 |
Pancytopenia following vivax malaria in a CLL patient.
Topics: Aged; Antimalarials; Artemisinins; Artesunate; Bone Marrow; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Malaria, Vivax; Male; Pancytopenia; Plasmodium vivax; Treatment Outcome | 2013 |
Hemophagocytic syndrome associated with severe Plasmodium vivax malaria in a child in Bikaner (northwestern India).
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Biopsy, Needle; Bone Marrow; Child; Ethanolamines; Female; Fluorenes; Humans; India; Liver Function Tests; Lumefantrine; Lymphohistiocytosis, Hemophagocytic; Malaria, Vivax; Plasmodium vivax; Primaquine; Schizonts; Treatment Outcome | 2013 |
Rare concurrent infection with scrub typhus, dengue and malaria in a young female.
Topics: Adult; Artemisinins; Artesunate; Blood Gas Analysis; Coinfection; Dengue; Doxycycline; Enzyme-Linked Immunosorbent Assay; Female; Humans; India; Malaria, Vivax; Oxygen; Platelet Transfusion; Polymerase Chain Reaction; Scrub Typhus | 2014 |
Uncomplicated Plasmodium vivax malaria in pregnancy associated with mortality from acute respiratory distress syndrome.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Fatal Outcome; Female; Humans; Malaria, Vivax; Mefloquine; Myanmar; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Stillbirth; Thailand | 2014 |
Cerebral malaria due to Plasmodium vivax in a young infant.
Topics: Anticonvulsants; Antimalarials; Artemisinins; Artesunate; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Cerebral; Malaria, Vivax; Phenytoin | 2014 |
In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Colombia; Drug Resistance; Malaria, Vivax; Mefloquine; Parasitic Sensitivity Tests; Plasmodium vivax; Quinine | 2014 |
Severe vivax malaria: a case report and a literature review.
Topics: Antimalarials; Artemisinins; Artesunate; Asian People; Diagnosis, Differential; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Severity of Illness Index; Young Adult | 2014 |
Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo.
Topics: Aged; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Humans; Liver; Malaria, Vivax; Male; Models, Biological; Papua New Guinea; Plasmodium vivax; Primaquine; Sporozoites; Thailand; Torpor | 2015 |
[Tracing Investigation of One Vivax Malaria Case by Detecting the Gene Encoding Circumsporozoite Protein in Henan].
Topics: Artemisinins; Artesunate; Humans; Malaria, Vivax; Molecular Sequence Data; Myanmar; Polymerase Chain Reaction | 2015 |
Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Topics: Amodiaquine; Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Resistance, Multiple; Erythrocytes; Fructose-Bisphosphate Aldolase; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria, Vivax; Mefloquine; Membrane Transport Proteins; Plasmodium vivax; Protozoan Proteins; Quinolines; Transcription, Genetic; Tubulin | 2016 |
Characterizing Types of Human Mobility to Inform Differential and Targeted Malaria Elimination Strategies in Northeast Cambodia.
Topics: Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Cambodia; Chloroquine; Disease Eradication; Health Surveys; Humans; Insect Vectors; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Transients and Migrants | 2015 |
Cerebral malaria in a man with Plasmodium vivax mono-infection: a case report.
Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Doxycycline; Female; Humans; Malaria, Cerebral; Malaria, Vivax; Male; Plasmodium vivax; Polymerase Chain Reaction; Seizures; Treatment Outcome; Young Adult | 2016 |
UK malaria treatment guidelines 2016.
Topics: Adult; Antimalarials; Artemisinins; Artesunate; Breast Feeding; Child; Child, Preschool; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Travel | 2016 |
Plasmodium vivax Malaria Presenting with Multifocal Hemorrhagic Brain Infarcts in a School-going Child.
Topics: Acute Febrile Encephalopathy; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Brain; Child; Clindamycin; Electroencephalography; Humans; Intensive Care Units, Pediatric; Intracranial Pressure; Malaria, Cerebral; Malaria, Vivax; Male; Plasmodium vivax; Treatment Outcome | 2016 |
Haemophagocytic lymphohistiocytosis (HLH): a rare but potentially fatal association with Plasmodium vivax malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Lymphohistiocytosis, Hemophagocytic; Malaria, Vivax; Male; Rare Diseases; Treatment Outcome; Young Adult | 2016 |
Severe Plasmodium vivax cerebral malaria complicated by hemophagocytic lymphohistiocytosis treated with artesunate and doxycycline.
Topics: Adult; Artemisinins; Artesunate; Doxycycline; Humans; Lymphohistiocytosis, Hemophagocytic; Malaria, Cerebral; Malaria, Vivax; Male; Plasmodium vivax | 2018 |
A Curious Case of "Septic Shock".
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Ceftriaxone; Drug Combinations; Female; Humans; Malaria, Vivax; Norepinephrine; Plasmodium vivax; Primaquine; Pyrimethamine; Shock, Septic; Sulfadoxine; Takayasu Arteritis; Vasoconstrictor Agents; Vasopressins | 2017 |
Autoimmune Hemolytic Anemia in Plasmodium vivax Malaria.
Topics: Anemia, Hemolytic, Autoimmune; Antimalarials; Artemisinins; Artesunate; Blood Transfusion; Glucocorticoids; Humans; Infant; Malaria, Vivax; Male; Prednisolone | 2017 |
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Chloroquine; Drug Therapy, Combination; Female; Humans; Inhibitory Concentration 50; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Multidrug Resistance-Associated Proteins; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Survival Analysis; Treatment Failure | 2009 |
Childhood cerebral vivax malaria with pancytopenia.
Topics: Animals; Artemisinins; Artesunate; Child; Female; Humans; Malaria, Cerebral; Malaria, Vivax; Pancytopenia; Plasmodium vivax; Trophozoites | 2009 |
Oral artesunate for neonatal malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Therapy, Combination; Humans; Infant, Newborn; Malaria, Vivax; Male; Plasmodium vivax; Treatment Outcome | 2010 |
Plasmodium vivax with acute glomerulonephritis in an 8-year old.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Glomerulonephritis; Humans; Malaria, Vivax; Male; Plasmodium vivax; Treatment Outcome | 2010 |
Three unusual presentations of plasmodium vivax malaria.
Topics: Adult; Animals; Antimalarials; Artemisinins; Artesunate; Chloroquine; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Primaquine; Respiratory Distress Syndrome; Shock; Splenic Infarction; Treatment Outcome | 2011 |
Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.
Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Dihydropteroate Synthase; DNA, Protozoan; Drug Combinations; Drug Resistance; Haplotypes; Humans; Infant; Iran; Malaria, Vivax; Middle Aged; Mutation; Plasmodium vivax; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Pyrimethamine; Sequence Analysis, DNA; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.
Topics: Aging; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Cohort Studies; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; New Guinea; Primaquine | 2012 |
Intravenous artesunate for transfusion-transmitted plasmodium vivax malaria in a preterm neonate.
Topics: Antimalarials; Artemisinins; Artesunate; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Malaria, Vivax; Transfusion Reaction | 2012 |
Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Brazil; Child; Child, Preschool; Drug Combinations; Female; Hospitalization; Humans; Incidence; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Treatment Outcome; Young Adult | 2012 |
New treatment policy of malaria as a part of malaria control program in Indonesia.
Topics: Antimalarials; Artemether; Artemisinins; Artesunate; Disease Eradication; Drug Resistance; Drug Therapy, Combination; Health Policy; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Practice Guidelines as Topic; Primaquine | 2012 |
A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Malaysia; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Plasmodium knowlesi; Plasmodium vivax; Prospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2013 |
Malaria and the heart.
Topics: Acute Coronary Syndrome; Adult; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Electrocardiography; Endemic Diseases; Heparin, Low-Molecular-Weight; Humans; Malaria, Vivax; Male; Nitrates; Thrombocytopenia | 2012 |
[Artemisinine and artesunate in the treatment of malaria in Vietnam (1984-1999)].
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Artemisinins; Artesunate; Child; Doxycycline; Drug Combinations; Drug Resistance; Drugs, Chinese Herbal; Humans; Malaria, Falciparum; Malaria, Vivax; Sesquiterpenes; Tetracycline; Vietnam | 2002 |
Diuretic effect of sodium artesunate in patients with malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Diuresis; Diuretics; Humans; Injections, Intravenous; Malaria, Falciparum; Malaria, Vivax; Male; Natriuresis; Renal Insufficiency; Sesquiterpenes | 2002 |
Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endemic Diseases; Female; Follow-Up Studies; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Monitoring, Physiologic; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Prospective Studies; Sesquiterpenes; Sulfadoxine; Suppositories; Treatment Outcome | 2003 |
Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Chloroquine; Female; Humans; Malaria, Vivax; Male; Middle Aged; Plasmodium vivax; Risk Assessment; Sesquiterpenes | 2004 |
Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
Topics: Animals; Antimalarials; Aotidae; Artemether; Artemisinins; Artesunate; Benzamidines; Chloroquine; Drug Resistance; Heterocyclic Compounds, 1-Ring; Inhibitory Concentration 50; Malaria, Vivax; Parasitemia; Peroxides; Plasmodium falciparum; Plasmodium vivax; Sesquiterpenes; Spiro Compounds; Time Factors | 2006 |
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
Topics: Adult; Aged; Antimalarials; Artemisinins; Artesunate; Cross-Sectional Studies; Drug Therapy, Combination; Early Diagnosis; Female; Hospital Mortality; Hospitalization; Humans; Incidence; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; National Health Programs; Parasitic Sensitivity Tests; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Refugees; Sesquiterpenes; Thailand; Tropical Climate | 2006 |
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Primaquine; Secondary Prevention; Sesquiterpenes | 2007 |
The risk of malarial infections and disease in Papua New Guinean children.
Topics: Adolescent; Animals; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; DNA, Protozoan; Female; Humans; Incidence; Longitudinal Studies; Malaria, Falciparum; Malaria, Vivax; Male; Papua New Guinea; Parasitemia; Plasmodium falciparum; Plasmodium vivax; Polymerase Chain Reaction; Risk Factors; Rural Population; Sesquiterpenes | 2007 |
Dynamics of asymptomatic Plasmodium vivax infections and Duffy binding protein polymorphisms in relation to parasitemia levels in Papua New Guinean children.
Topics: Adolescent; Amino Acid Sequence; Animals; Antigens, Protozoan; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Haplotypes; Humans; Malaria, Vivax; Papua New Guinea; Parasitemia; Phylogeny; Plasmodium vivax; Polymorphism, Genetic; Protozoan Proteins; Receptors, Cell Surface; Sesquiterpenes | 2007 |